Anti-miR-33b treatment upregulated miR-33 target genes including CDK6, FST, and ABCA1, as well as utrophin in myotubes differentiated from DMD patient-derived iPS cells, consistent with the observation in mice (Appendix Fig. S12B; Fig. 9F,G). The gene discussed is UTRN; the disease is Duchenne muscular dystrophy.